C5orf34, on the other hand, was shown to be less expressed in several malignancies, including leukemia, prostate cancer, lymphoma, breast cancer, ovarian cancer, and central nervous system cancer (Figure 1A). The gene discussed is C5orf34; the disease is breast carcinoma.